Novartis' Bet Pays Off as Advanced Accelerator Applications Wins FDA Nod for Lutathera Post author:Sam Post published:January 25, 2018 Post category:BioPharma The drug is the first available FDA-approved Peptide Receptor Radionuclide Therapy. Source: BioSpace You Might Also Like 9 Questionable Drugs Biotechs Are Submitting to the FDA in a Hail Mary Pass March 8, 2017 New Jersey's Leading Pharma, LLC Scores $40M January 7, 2018 INC Research And Celebrate Clinical Trials Awareness Week Through Release Of New Educational Animation May 3, 2017
INC Research And Celebrate Clinical Trials Awareness Week Through Release Of New Educational Animation May 3, 2017
